{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:25:09Z","timestamp":1791901509094,"version":"4.3.4"},"reference-count":26,"publisher":"PeerJ","license":[{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Health System Research Institute through the National Health Foundation","award":["CNB 62001"],"award-info":[{"award-number":["CNB 62001"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Many countries now allow the consumption of cannabis or cannabinoids for medical purposes with varying approaches concerning products allowed and the regulatory frameworks prevailing their endowment. On 18 February 2019 Thailand passed legislation allowing the use of cannabis for medical purposes. This study aimed to examine patterns and purposes for consumption of medical cannabis, and consumers\u2019 perceptions and opinions towards benefits and harms of cannabis and related policies in 2019\u20132020.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional study using a respondent-driven sampling (RDS) method was conducted in four sites across Thailand. Participants were 485 adults aged 18 years and over, living in the study region, who had used cannabis for medical purposes within the past 12 months. Face-to-face interviews using a structured questionnaire were used to collect data on (1) demographic characteristics, (2) pattern of consumption, (3) source of information and perception of benefits and harms of medical cannabis, and (4) opinion towards cannabis policies. Data were analyzed using RDS Analyst and presented as percentage and mean with 95% confidence interval (CI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Most participants (84.7%, 95% CI [78.9\u201390.5]) used an oral form of crude oil extract while 9.2% (95% CI [4.1\u201314.2]) used the raw form. The most common uses were for treatment of cancers (23.3%, 95% CI [16.1\u201330.4]), neuropsychiatric symptoms (22.8%, 95% CI [17.5\u201328.0]), and musculoskeletal pains (21.6%, 95% CI [16.7\u201326.6]). Illegal sources such as underground traders (54.5%, 95% CI [40.8\u201368.3]), friends and relatives (12.2%, 95% CI [6.2\u201318.3]), not-for-profit provider groups (5.2%, 95% CI [0.5\u201310.9]), and clandestine growers or producers (2.9%, 95% CI [0.6\u20135.3]) were the main suppliers. Most (&gt;80%) perceived cannabis could treat cancers, chronic pains, insomnia, Parkinson\u2019s disease and generalized anxiety disorder. Less than half perceived that cannabis could cause adverse conditions\n                      <jats:italic>e.g.,<\/jats:italic>\n                      palpitation, panic, memory impairment and schizophrenic-like psychosis. Most respondents agreed or strongly agreed with the policies regarding permission to use cannabis for medical purposes (95.1%, 95% CI [92.0\u201398.2]), for the legal sale of medical cannabis products (95.9%, 95% CI [93.7\u201398.2]), and for people to grow cannabis for medical use (94.2%, 95% CI [91.8\u201396.5]). However, only two-thirds agreed with policies concerning the sales of cannabis (65.3%, 95% CI [56.9\u201373.7]) and home-grown cannabis for recreational purposes (61.3%, 95% CI [52.7\u201369.9]).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study reports the experiences of consumers of medical cannabis in the first year after its legalization in Thailand. Consumers reported various patterns and indications of consumption that were not supported by scientific evidence, but had positive perception of the results of consumption. These findings highlight ongoing policy challenges for Thailand and can be a lesson to be learned for other countries in the region.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.7717\/peerj.12809","type":"journal-article","created":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T03:54:53Z","timestamp":1641873293000},"page":"e12809","source":"Crossref","is-referenced-by-count":27,"title":["Medical cannabis use in Thailand after its legalization: a respondent-driven sample survey"],"prefix":"10.7717","volume":"10","author":[{"given":"Sawitri","family":"Assanangkornchai","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanittha","family":"Thaikla","sequence":"additional","affiliation":[{"name":"Research Institute for Health Sciences, Chiang Mai University, Muang, Chiang Mai, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammadfahmee","family":"Talek","sequence":"additional","affiliation":[{"name":"Faculty of Nursing Pattani Campus, Prince of Songkla University, Muang, Pattani, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darika","family":"Saingam","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4443","published-online":{"date-parts":[[2022,1,11]]},"reference":[{"key":"10.7717\/peerj.12809\/ref-1","volume-title":"National household survey to estimate the population size of substance users in Thailand","author":"Administrative Committee of Substance Academic Network","year":"2019"},{"key":"10.7717\/peerj.12809\/ref-2","volume-title":"Medicinal cannabis policies and practices around the world","author":"Aguilar","year":"2018"},{"key":"10.7717\/peerj.12809\/ref-3","volume-title":"A survey on knowledge, understanding and opinion of Thais aged 15 and over on medical and recreational use of cannabis","author":"Centre for Addiction Studies","year":"2020"},{"key":"10.7717\/peerj.12809\/ref-4","article-title":"Medical cannabis clinic","author":"Committee for Public Relations on Medical Cannabis of the Ministry of Public Health","year":"2021"},{"key":"10.7717\/peerj.12809\/ref-5","volume-title":"Guidance on cannabis for medical use","author":"Department of Medical Services","year":"2020"},{"key":"10.7717\/peerj.12809\/ref-6","volume-title":"Medical use of cannabis and cannabinoids: questions and answers for policymaking","author":"European Monitoring Centre for Drugs and Drugs Addiction","year":"2018"},{"key":"10.7717\/peerj.12809\/ref-7","article-title":"RDS Analyst: Software for the analysis of respondent-driven sampling data","author":"Handcock","year":"2014"},{"key":"10.7717\/peerj.12809\/ref-8","doi-asserted-by":"publisher","first-page":"174","DOI":"10.2307\/3096941","article-title":"Respondent-driven sampling: a new approach to the study of hidden populations","volume":"44","author":"Heckathorn","year":"1997","journal-title":"Social Problems"},{"key":"10.7717\/peerj.12809\/ref-9","doi-asserted-by":"publisher","first-page":"174","DOI":"10.2307\/3096941","article-title":"Respondent-driven sampling: a new approach to the study of hidden populations*","volume":"44","author":"Heckathorn","year":"2014","journal-title":"Social Problems"},{"key":"10.7717\/peerj.12809\/ref-10","article-title":"Introduction to respondent driven sampling to HIV\/AIDS and sexually transmitted infection surveillance. Module 4","volume-title":"Introduction to respondent driven sampling. 2013","author":"Johnston","year":"2013"},{"key":"10.7717\/peerj.12809\/ref-11","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.3390\/jcm9061925","article-title":"The impact of marijuana on the cardiovascular system: a review of the most common cardiovascular events associated with marijuana use","volume":"9","author":"Latif","year":"2020","journal-title":"Journal of Clinical Medicine"},{"key":"10.7717\/peerj.12809\/ref-12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12954-020-00377-0","article-title":"Medical cannabis use in the Australian community following introduction of legal access: the 2018-2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18)","volume":"17","author":"Lintzeris","year":"2020","journal-title":"Harm Reduction Journal"},{"key":"10.7717\/peerj.12809\/ref-13","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.drugpo.2017.01.011","article-title":"Medical cannabis access, use, and substitution for prescription opioids and other substances: a survey of authorized medical cannabis patients","volume":"42","author":"Lucas","year":"2017","journal-title":"International Journal of Drug Policy"},{"key":"10.7717\/peerj.12809\/ref-14","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ypmed.2017.01.024","article-title":"Public perceptions of arguments supporting and opposing recreational marijuana legalization","volume":"99","author":"McGinty","year":"2017","journal-title":"Preventive Medicine"},{"key":"10.7717\/peerj.12809\/ref-15","article-title":"Medical cannabis","author":"Ministry of Public Health of Thailand","year":"2020"},{"key":"10.7717\/peerj.12809\/ref-16","article-title":"Narcotics Act (7) B.E.2562","author":"Government of Thailand","year":"2019"},{"key":"10.7717\/peerj.12809\/ref-17","volume-title":"The health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research","author":"National Academies Press for the National Academies of Sciences Engineering and Medicine","year":"2017"},{"key":"10.7717\/peerj.12809\/ref-18","volume-title":"Summary of the survey results on working status of the population, 2020","author":"National Statistics Office, Ministry of Digital Economy and Society","year":"2020"},{"key":"10.7717\/peerj.12809\/ref-19","article-title":"Survey on cannabis policy","author":"National Institute of Development Administration of Thailand","year":"2019"},{"key":"10.7717\/peerj.12809\/ref-20","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1080\/10826084.2018.1543327","article-title":"Understanding public attitudes toward cannabis legalization: qualitative findings from a statewide survey","volume":"54","author":"Resko","year":"2019","journal-title":"Substance Use & Misuse"},{"key":"10.7717\/peerj.12809\/ref-21","volume-title":"A study of social discourses towards medical and recreational cannabis in mass media in Thailand","author":"Runkasem","year":"2020"},{"key":"10.7717\/peerj.12809\/ref-22","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1089\/can.2016.0007","article-title":"A cross-sectional survey of medical cannabis users: patterns of use and perceived efficacy","volume":"1","author":"Sexton","year":"2016","journal-title":"Cannabis and Cannabinoid Research"},{"key":"10.7717\/peerj.12809\/ref-23","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1126\/science.aaf7450","article-title":"Federal barriers to cannabis research","volume":"352","author":"Stith","year":"2016","journal-title":"Science"},{"key":"10.7717\/peerj.12809\/ref-24","first-page":"146","article-title":"The cardiovascular effects of marijuana: are the potential adverse effects worth the high?","volume":"116","author":"Subramaniam","year":"2019","journal-title":"Mo Med"},{"key":"10.7717\/peerj.12809\/ref-25","first-page":"4","article-title":"Precautions for cannabis use","author":"Toxicology Center Ramathibodi Hospital Mahidol University","year":"2020"},{"key":"10.7717\/peerj.12809\/ref-26","first-page":"109","article-title":"Therapeutic benefits of cannabis: a patient survey","volume":"73","author":"Webb","year":"2014","journal-title":"Hawaii Journal of Health & Social Welfare"}],"container-title":["PeerJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/peerj.com\/articles\/12809.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/12809.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/12809.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/12809.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T03:55:07Z","timestamp":1641873307000},"score":1,"resource":{"primary":{"URL":"https:\/\/peerj.com\/articles\/12809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,11]]},"references-count":26,"alternative-id":["10.7717\/peerj.12809"],"URL":"https:\/\/doi.org\/10.7717\/peerj.12809","archive":["CLOCKSS","LOCKSS","Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.7287\/peerj.12809v0.1\/reviews\/1","asserted-by":"object"},{"id-type":"doi","id":"10.7287\/peerj.12809v0.1\/reviews\/2","asserted-by":"object"},{"id-type":"doi","id":"10.7287\/peerj.12809v0.2\/reviews\/2","asserted-by":"object"},{"id-type":"doi","id":"10.7287\/peerj.12809v0.2\/reviews\/1","asserted-by":"object"}]},"ISSN":["2167-8359"],"issn-type":[{"value":"2167-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,11]]},"article-number":"e12809"}}